Then, we further analyzed the expressions of PKM2 in ER+ and triple negative breast cancer by TCGA and found that there was no significant difference in the levels of PKM2 between ER+ and triple negative breast cancer tissues (Supplemental Figure 1A). Here, PKM is linked to triple-negative breast carcinoma.